EAP EBITDA multiples are the question behind every other question. Owners ask “what is my company worth,” but what they usually mean is: what are businesses like mine actually selling for? This guide gives you the most honest answer available — the published behavioral health benchmarks that frame EAP transactions, what moves a company up or down within them, and why the platform-versus-add-on distinction matters more than any single number.
EAP-specific transactions are almost always privately reported. There is no public ticker of employee assistance program deals, and any advisor quoting you a precise “EAP multiple” without qualification is projecting. What does exist is a well-documented benchmark set for the behavioral health services sector that EAP companies transact within — and a clear pattern for how recurring-revenue, employer-contracted businesses get treated inside it.
Per FOCUS Investment Banking’s behavioral health EBITDA multiples data (published December 2025, updated February 2026), valuations in the sector split sharply by transaction type:
| Transaction type | EBITDA multiple range |
|---|---|
| Platform companies (scaled, infrastructure-ready) | 7x – 10x |
| Add-on acquisitions (folded into an existing platform) | 3x – 9x |
Within the sector, the mental health / outpatient psychiatry segment — the closest published neighbor to EAP services — showed platform deals at 10x–14x and add-ons at 4x–8x in 2025, per the same source.
Two implications for EAP owners. First, the spread within the add-on range is wide — the difference between the bottom and top of 3x–9x on the same EBITDA is the entire value of many companies. Second, the platform premium is real and large, which is where the multiple arbitrage covered in our consolidation guide comes from.
In our analysis, the EAP model carries features buyers in this sector consistently pay up for — and a few they consistently discount:
Size matters too. Companies under roughly $1M in earnings are typically priced on a seller’s discretionary earnings basis at lower cash-flow multiples — the buyer is purchasing a job as well as a business. Above that line, the EBITDA framework and the ranges in the table start to apply. The methodology behind the earnings figure itself is covered in EAP Business Valuation: What Your Company Is Actually Worth.
The benchmark table above assumes a company large enough to be valued on an EBITDA basis. Below roughly $1M in earnings, most transactions price on seller’s discretionary earnings (SDE) instead — a measure that adds back the owner’s full compensation on the assumption that the buyer is stepping into the operating role. SDE multiples run meaningfully lower than EBITDA multiples, which sometimes surprises owners comparing their outcome to headline platform deals. The practical takeaway: crossing the threshold where a buyer can underwrite your company on an EBITDA basis — with management in place and the owner replaceable — is itself one of the largest value events available to a smaller EAP.
A worked example makes the stakes concrete. Take an EAP producing $1.5M in defensible adjusted EBITDA. At 4x — the bottom of the mental health add-on range — that’s $6.0M. At 8x, the top of the same published range, it’s $12.0M. Same company, same earnings; the spread is determined by the drivers in this article and by how competitively the company is brought to market.
Multiples hold up when the underlying market supports them. The employee assistance program services market grew from $7.36 billion in 2024 to an estimated $7.79 billion in 2025 and is projected to reach $11.65 billion by 2032 — roughly 5.9% annual growth, per Research and Markets. Meanwhile behavioral health M&A activity has remained strong, with sponsors continuing to build platforms across mental health services. Growth plus active consolidation is the combination that keeps quality books in demand — and it’s why the benchmarks above have held their shape even as rate conditions shifted. We track the full picture, refreshed quarterly, in the 2026 EAP M&A Market Update.
So what are EAP companies selling for in 2026? Within the published behavioral health ranges above — with the specific EAP company EBITDA multiple in any deal set by contract quality, concentration, and evidence. Owners comparing EBITDA multiples by industry should read the behavioral health row as their frame, then adjust for the EAP model’s recurring-revenue advantages. Multiples describe outcomes, not offers. A platform buyer with existing EAP infrastructure prices your book against their synergies; a payer prices your network and data; a strategic prices coverage gaps you happen to fill. That’s why two credible buyers can land two or three turns of EBITDA apart on identical financials — and why the single most reliable way to reach the top of your range is a competitive process where several of them price you at once. In Olympic M&A’s own EAP work, that competitive dynamic has added seven figures against an opening offer.
Because EAP comps are private, owners are especially exposed to confident-sounding numbers with nothing behind them. A few questions separate real guidance from projection:
An advisor who answers all four cleanly is describing your company. One who can’t is describing a brochure.
The levers are unusually concrete in this industry, because so much of the diligence is contractual:
The full 12–24 month program is in How to Maximize the Value of Your EAP Business Before a Sale.
Get a directional number from the EAP business valuation calculator, then see the full sell-side roadmap in How to Sell an EAP Business: The Complete Owner’s Guide. Wondering who’s actually paying these multiples? Start with What Buyers Look for in EAP Businesses.
Lengthen contracts, reduce client concentration, build clean utilization evidence, deepen the team beyond the founder, and document every add-back. These are the exact variables buyers underwrite, and 12–24 months of deliberate work on them routinely moves a company materially within — or above — its starting range.